TELEMEDICINE BY DESHVIKASH in covid19 pandemic

TELEMEDICINE BY DESHVIKASH in covid19 pandemic

1. COVID-19 Pandemic and Implementing TELEMEDICINE
ὸH
By: DESHVIKASH SWAIN
Caption

2. Coronavirus are the viruses that can affect both animal and
humans.
They are respiratory viruses as the name suggest crown like
spikes on their surface.These viruses are culprit in several
outbreaks across the globes ,so we introduce telemedicine.
Telemedicine has experienced substantial expansion and
uptake in recent times.
Technological progress has played a crucial role in enabling
the broadening of telemedicine offerings.
Telemedicine has demonstrated its value in enhancing
healthcare accessibility, particularly in remote regions.
WHAT IS CORONAVIRUS?

3. COVID-19 symptoms appears
about 2-14 days after exposure
to the Covid virus. People who
test positive for COVID-19
typically have symptoms for a
couple weeks. People who have
long COVID (also known as long-
haulers) can have persistent
symptoms that last at least 12
weeks after infection

4. SYMPTOMS OF COVID-19:
●Fever or chills.
●Cough.
●Shortness of breath.
●Fatigue.
●Muscle or body aches.
●Headache.

5. Worsening COVID-19 symptoms
Worsening symptoms can include:
●new or worse trouble with breathing
●severe dehydration such as a very dry mouth, not peeing
very much, feeling lightheaded or dizzy
●severe headache.
●If symptoms get worse or you need advice on how to
manage them, call your:
●doctor
●usual healthcare provider

6. People at risk of severe illness from COVID-19
You are at higher risk of severe illness from COVID-19 if you:
●have a weakened immune system
●have a high-risk medical condition
●are older
●are an infant under the age of 1 month
●are a child under the age of 2 who was born premature (less
than 37 weeks)
●are a child with multiple chronic condition

7. How COVID-19 spreads:
COVID-19 spreads from person to person. When an infected person
breathes, speaks, coughs, sneezes or sings, they may spread particles
containing the virus. It is more likely that COVID-19 will spread through
the air than on surfaces, but both are possible.
There are 3 main ways you can get COVID-19.
Breathing in air with COVID-19 particles.
COVID-19 particles landing on your mouth, nose or eyes, for example,
from a cough or sneeze.
Touching your mouth, nose or eyes when your hands have the virus
on them, either through direct contact with someone or by touching
contaminated surfaces.

8. When COVID-19 is more likely to spread
A person is most infectious and more likely to spread COVID-19 in
the few days around the time that symptoms develop. This means
that some individuals can be infectious before they develop
symptoms.
Your risk of getting COVID-19 increases when you are:
●near a person with COVID-19
●near that person for a long time
●in a poorly ventilated indoor space
●in enclosed spaces that do not have good airflow
●in crowded places with many people nearby
●in close-contact settings, such as close-range conversations,
singing, or shouting.

10. What are the stages and symptoms of COVID-19?
Day 1: The symptoms usually start with a fever, a dry cough and mild breathing issues
which may get worse over the next week. You also may have symptoms of a sore throat,
coughing up mucus, diarrhea, nausea, body aches and joint pain.
Day 7: Breathing may become difficult or laboured. This is called dyspnoea.
Day 9: Sepsis may start, this is the body's extreme response to an infection that can lead
to organ failure or injury.
Day 10-12: People who have mild COVID-19 start to have an improvement in their fever
and cough, but in serious cases their fever and cough continues.
Acute respiratory distress syndrome (ARDS) starts to be diagnosed, this is a respiratory
problem when there is widespread inflammation in the lungs.
Day 12: This is the median day to be admitted into the intensive care unit (ICU).
Day 15: Acute kidney and cardiac injury becomes evident.
Day 18.5: The median time it takes from the first symptoms of COVID-19 to death is 18.5
days.
Day 22: This is the median amount of days it takes for COVID-19 survivors to be released
from hospital

11. The use of telemedicine was quite limited in most OECD countries before the COVID-19 pandemic,
held back by regulatory barriers and hesitancy from patients and providers. In early 2020, as COVID-
19 massively disrupted in-person care, governments moved quickly to promote the use of
telemedicine. The number of teleconsultations skyrocketed, playing a vital role in maintaining
access to care, but only partly offsetting reductions in in-person care. This report provides an
overview of the use of telemedicine in OECD countries, describing how governments scaled up
remote care during the pandemic and exploring the impact that this massive shift to remote care
has had on health care system performance. Telemedicine may be here to stay, but questions
remain concerning how to regulate its use, how to pay for it, how to integrate it with in-person care,
and how to make sure that it constitutes good value for money for all. This report puts forth priorities
for policy makers to inform the discussion and to promote the best use of remote care services in the
future.
USE OF TELEMEDICINE DURING CORONA PANDEMIC

12. The use of telemedicine, or the provision of
healthcare and communication services
through distance-based technologies, has
increased substantially since the 2019 novel
coronavirus (COVID-19) pandemic. However,
it is still unclear what are the innovative
features of the widespread use of such
modality, its forms of employment and the
context in which it is used across pluralist
health systems, particularly in low- and
middle-income settings. We have sought to
provide empirical evidence on the above
issues by analysing the responses of medical
doctors in a representative cross-sectional
survey in two states in Brazil.

13. Limitations to telehealth from COVID-19?
Telemedicine can be a tool for managing COVID19. However, there is one glaring
disconnect that must resolve, said John Nosta, president of NostaLab, a digital health
think tank.
“The basis for out-of-hospital management is testing,” he said. “The linchpin of
management of a pandemic is widespread testing and conventional telemedicine
today may not offer that. Perhaps a ‘crisis-based’ evolution of telemedicine can help find
local testing centers and also manage the flow of patients seeking a test.”
With respect to COVID19, the data suggests that most people will have a mild infection
and the clinical course will be unremarkable. In these instances, telemedicine may not
really be all that necessary, Nosta said.
“However, for a smaller subset of higher risk patients, the clinical course may not be
consistent with conventional telemedicine,” he explained. “These patients often present
with a more serious condition that results in rapid decompensation and requires
hospitalization. The reality might be that for COVID19, telemedicine, as it exists now,
needs to be modified to help manage early testing, diagnosis and triage for those who
may require in-patient care.”

14. Treatments for COVID-19
The treatments available for people at the highest risk of becoming seriously ill from
COVID-19 are:
nirmatrelvir plus ritonavir (Paxlovid)
sotrovimab (Xevudy)
molnupiravir (Lagevrio)
remdesivir (Veklury)
How to get COVID-19 treatment
Keep rapid lateral flow tests at home
Take a rapid lateral flow test if you get symptoms
If your test is positive, call your GP surgery, NHS 111 or hospital specialist
If your test is negative, do a total of 3 tests over 3 days
If your test result is negative, but you still have symptoms of COVID-19, you need to
do a total of 3 rapid lateral flow tests over 3 days.

15. COVID-19 Prevention
CDC guidelines regarding COVID-19 prevention
include:
●Stay current with COVID-19 vaccinations.
●Get tested for COVID-19 if you have symptoms.
●Follow recommendations for taking certain steps to
prevent spreading COVID-19 if you've been exposed.
●Move indoor activities outdoors.
●Isolate if you suspect you have or have a confirmed
case of COVID-19.
●Stay away from others with suspected or confirmed
cases.
●Improve the flow of air in and out of rooms, which can
include opening windows, changing air filters more
often, turning on fans or exhaust fans, and using HEPA
(high efficiency particulate air) cleaners.
●Get treatment if you have COVID-19 and are
considered high risk of getting very sick.

16. A COVID‑19 vaccine is a vaccine intended to provide
acquired immunity against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the virus that
causes coronavirus disease 2019 (COVID‑19).
COVID-19 Vaccine
There are two types of COVID-19 vaccines
available in the United States: mRNA vaccines
and protein subunit vaccines. CDC recommends the
2023–2024 updated COVID-19 vaccines: Pfizer-
BioNTech, Moderna, or Novavax, to protect against
serious illness from COVID-19.
The Moderna COVID-19 Vaccine (2023-2024
Formula) includes a monovalent (single) component
that corresponds to the Omicron variant XBB. 1.5 of
SARS-CoV-2. The Moderna COVID-19 Vaccine (2023-
2024 Formula) is authorized for all doses administered
to individuals 6 months through 11 years of age to
prevent COVID-19.

17. Conclusion
Telemedicine, an innovative method of delivering healthcare services through digital
communication, has experienced an unprecedented surge in adoption, particularly during the
global pandemic. In this research, we delve into the analysis and interpretation of survey data to
obtain comprehensive insights into the effectiveness, challenges, and potential impacts of
telemedicine in modern healthcare. By collecting data from a diverse group of participants,
including various age groups, genders, and nationalities, our survey provides a panoramic view
of the current status and future prospects of telemedicine in the continually evolving healthcare
landscape.
The use of telehealth improves the provision of health services. Therefore, telehealth should
be an important tool in caring services while keeping patients and health providers safe
during COVID-19 outbreak.
It’s important to take all preventive measures and to take vaccination and to eat
immunity booster foods.